Telesis Bio, Inc. (TBIO)

Overview

Telesis Bio, Inc. is a leading synthetic biology company known for producing and distributing a range of synthetic biology instruments, reagents, and associated products and services to a global customer base, which includes pharmaceutical and academic laboratories. Originally founded as Codex DNA, Inc., the company underwent a rebranding, adopting the name Telesis Bio, Inc. in November 2022. Established in 2011, Telesis Bio has its headquarters situated in San Diego, California. The company excels in converting digital DNA sequences into synthetic DNA and mRNA, streamlining research and development processes in fields such as vaccine development, diagnostics, therapeutics, and personalized medicine. It caters to diverse clientele including government institutions, contract research organizations, and synthetic biology companies.

Products and Services

• BioXp 3250 system and BioXp 9600 system: These cutting-edge systems facilitate researchers in transforming digital DNA sequences into synthetic DNA and mRNA end products. They also support next-generation sequencing (NGS) library preparation, streamlining the research process from sequence design to synthesis.
• BioXp portal: An intuitive online platform offering guided workflows and design tools. It enables users to construct new DNA sequences and integrate them into desired vectors or mRNA constructs, enhancing the efficiency of synthetic biology projects.
• BioXp De Novo kits: These kits provide essential building blocks and reagents, including the proprietary Gibson assembly reagents, tailored for specific synthetic biology applications. They are designed to facilitate the construction of synthetic biology workflow applications from scratch.
• BioXp Select kits: These kits allow researchers to utilize non-Telesis Bio DNA with the BioXp system for executing various synthetic biology workflows such as cloning, plasmid-based mRNA generation, and cell-free amplification.
• BioXp Next Generation Sequencing kits: Containing all necessary reagents, these kits enable a seamless transition from extracted DNA or RNA to a library ready for next-generation sequencing, supporting comprehensive genomic analysis.
• Benchtop reagents: These reagents are designed for executing specific synthetic biology workflows manually on the benchtop, using products generated by the BioXp system. They are crucial for researchers who prefer or require manual intervention in their protocols.
• Custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions: Tailor-made solutions provided by Telesis Bio facilitate the construction of synthetic DNA, RNA, and proteins. These are crucial for the development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines, showcasing the company’s commitment to advancing healthcare through synthetic biology.